Australian Dairy Nutritionals Limited · ASX:AHF
Australian Dairy Nutritionals — Shareholder Meeting (February 2021)
20 slides from Australian Dairy Nutritionals's shareholder meeting presentation, Feb 18, 2021
Slide 1: Growing Local, Going Global – Extraordinary General Meeting of Shareholders
Growing Local, Going Global Extraordinary General Meeting of Shareholders 18 February 2021
Slide 2: Welcome
@) Australian Dairy *@ Nutritionals Group Welcome
Slide 3: Agenda
Agenda Welcome CEO Presentation Consideration of Items of Business per Notice of Meeting • Resolution 1: Ratification of issue of Tranche 1 Securities under the Placement • Resolution 2: Approval of Proposed Issue of Tranche 2 Securities under the Placement • Resolution 3: Ratification of Securities
Slide 4: Zoom Meeting
Zoom Meeting Securityholders can listen to the meeting via Zoom with the following details: www.zoom.us Note: Securityholders cannot vote or ask questions through the Zoom platform during the Meeting 4
Slide 5: CEO Presentation
CEO Presentation 5
Slide 6: Capital Raising – Placement, SPP & Director Placement
• Capital raising process commenced in December 2020 comprising Capital Placement to sophisticated investors, SPP and Director Placement • Placement: AHF accepted subscriptions from sophisticated investors for Raising – 108,333,334 new AHF Securities at $0.06 per security, raising $6.5 million befor
Slide 7: Approvals & Use of Funds
Approvals Required • Resolution 1 seeks ratification of Tranche 1 of the Placement which Approvals & completed on 22 December 2020 raising $3.3 million with the issue of 55,272,898 new stapled securities Use of Funds • Resolution 2 seeks approval for tranche 2 of the Placement through the issue of 5
Slide 8: Acquisition of High Speed Blend & Packaging Line
Acquisition of High Speed Blend & Packaging Line • AHF has secured the right to purchase a high-speed blending and canning line from FA Maker Pty Ltd which includes 2 Bosch fillers for infant formula tins and nutritional powder bags • High-capacity line with ability to produce in excess of 20 millio
Slide 9: Future (Tummy Health) Formula Range Launch in Q4 FY21
Future (Tummy Health) Formula Range Launch in Q4 FY21 AHF will be launching a scientifically developed formula which will position AHF to capture market share in a high-margin product category Commentary Product Innovation Unique product range innovation to be disclosed closer to launch Matches
Slide 10: Ecklin South Organic A2 Infant Formula Launch in Q2 FY22
Ecklin South Organic A2 Infant Formula Launch in Q2 FY22 AHF recent transformation over the past three years has provided the platform for AHF to launch another unique infant formula product Commentary Very few producers globally of organic A2 infant formula, therefore opportunity to price at a pr
Slide 11: Business of Meeting
Business of Meeting Business of Meeting 11
Slide 12: Resolution 1 – Ratification of Issue of Tranche 1 Securities under the Placement
Resolution 1 – Ratification of Issue of Tranche 1 Securities under the Placement “That, for the purpose of Listing Rule 7.4 and for all other purposes, Securityholders approve, ratify and confirm the prior issue of 55,272,898 Stapled Securities as set out in the Explanatory Statement which accompani
Slide 13: Resolution 2 – Approval of Proposed Issue of Tranche 2 Securities
Resolution 2 – Approval of Proposed Issue of Tranche 2 Securities under the Placement “That, for the purpose of Listing Rule 7.1 and for all other purposes, Securityholders approve the issue of up to 53,060,436 Stapled Securities at an issue price of $0.06 (6 cents) per Stapled Security on the terms
Slide 14: Resolution 3 – Ratification of Securities Issued for Blend & Pack Line
Resolution 3 – Ratification of Securities Issued in respect of the Acquisition of the Blend & Pack Line “That, for the purpose of Listing Rule 7.4 and for all other purposes, Securityholders approve, ratify and confirm the prior issue of 450,068 Stapled Securities in part consideration of the paymen
Slide 15: Resolution 4 – Approval of Issue of Securities for Blend & Pack Line
Resolution 4 – Approval of Proposed Issue of Securities in respect of the Acquisition of the Blend & Pack Line “That, for the purpose of Listing Rule 7.1 and for all other purposes, Securityholders approve the issue of up to 1,500,000 Stapled Securities in part consideration of the payment of the pu
Slide 16: Resolution – Withdrawn
Business of Meeting Resolution 5 – Withdrawn 16
Slide 17: Resolution 6 – Approval of Proposed Placement to Directors
Resolution 6 – Approval of Proposed Placement to Directors “That, for the purpose of Listing Rule 10.11 and for all other purposes, Securityholders approve the issue of up to 4,000,000 Stapled Securities at an issue price of $0.06 (6 cents) per Stapled Security to Directors and their controlled enti
Slide 18: Resolution 7 – Approval of Proposed Issue of Options to Lead Manager
Resolution 7 – Approval of Proposed Issue of Options to Lead Manager “That for the purpose of Listing Rule 7.1 and for all other purposes, Securityholders approve the issue of 3,000,000 Options to Blue Ocean Equities Pty Ltd’s nominee, L39 Pty Ltd on the terms set out in Business of Meeting this Exp
Slide 19: Questions
@) Australian Dairy © Nutritionals Group Questions
Slide 20: Thank you
@) Australian Dairy © Nutritionals Group Thank you
Australian Dairy Nutritionals — Shareholder Meeting (February 2021) on 6ix